SAB Biotherapeutics- Unit (1 Ordinary share & 1/2 Wrt) Overview

SAB Biotherapeutics- Unit (1 Ordinary share & 1/2 Wrt) Selling, General & Admin

Selling, General & Admin expenses for BCYPU.

Quarterly SG&A Expenses

$5.87M

↑ 88.42% YoY

As of Mar 31, 2026

Annual SG&A Expenses (TTM)

$17.36M

↑ 21.26% YoY

Trailing 12 months ending Mar 31, 2026

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin